Publication | Open Access
Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
66
Citations
38
References
2016
Year
Cancer ImmunosurveillanceMedicineMelanomaHematologyImmunologyImmune Checkpoint InhibitorMelanoma PatientsDermatologyImmunotherapyBlood-borne Vδ1+Overall Survival
| Year | Citations | |
|---|---|---|
Page 1
Page 1